You are here: Home » International » News » Companies
Business Standard

Early studies of potential coronavirus treatment show promise: Pfizer

It also finalised a plan to develop a coronavirus vaccine in partnership with German drugmaker BioNTech SE and said the companies hope to produce millions of vaccines by the end of 2020.

Topics
Coronavirus | Pfizer

Reuters 

US drugmaker Pfizer said on Thursday that early data has helped it identify a drug candidate with the potential to help treat patients infected with the novel coronavirus. It also finalised a plan to develop a coronavirus vaccine in partnership with German drugmaker BioNTech SE and said the companies hope to produce millions of vaccines by the end of 2020. The companies said they plan to start trials of the vaccine as early as this month. Data from preclinical studies of a compound that was originally developed to treat SARS — a different coronavirus that caused a ...

This article is no longer available in our repository.

There could be multiple reasons for this.

First Published: Sat, April 11 2020. 01:07 IST
RECOMMENDED FOR YOU
.